Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
Ariad Pharmaceuticals will present data from the ongoing Phase 2 ALTA trial of its investigational lung cancer drug brigatinib at the upcoming 17th World Conference on Lung Cancer (WCLC). ... Read more
Administering a blood test at the time of a lung cancer diagnosis can provide physicians with important information about the genetic mutations of the cancer, which largely determine treatment ... Read more
Opdivo (nivolumab) is a safe and viable option for pre-treating patients with early stage lung cancer before surgery, according to data recently presented during the European Society for Medical ... Read more
Lung cancer research may have just taken a considerable leap forward — a recent study reports that a computer using a machine-learning approach was trained to predict the type, severity, and prognosis of such cancers ... Read more
Using endosonography to determine lung cancer metastases in the upper chest was found more sensitive in detecting cancer spread that surgical procedures, yet it did not improve survival in patients, a ... Read more
Whole brain radiation of brain metastases in lung cancer patients does not improve survival and quality of life more than treatment with steroids or other supportive care in most patients, ... Read more